Validity Assessment of Self-reported Medication Use for Hypertension, Diabetes, and Dyslipidemia in a Pharmacoepidemiologic Study by Comparison With Health Insurance Claims-Reference-Cited by-同舟云学术

Validity Assessment of Self-reported Medication Use for Hypertension, Diabetes, and Dyslipidemia in a Pharmacoepidemiologic Study by Comparison With Health Insurance Claims

Published:2021-09-05 Issue:9 Volume:31 Page:495-502
ISSN:0917-5040
Container-title:Journal of Epidemiology
language:en
Short-container-title:Journal of Epidemiology

Author:

Matsumoto Minako¹^ORCID,Harada Sei¹^ORCID,Iida Miho¹,Kato Suzuka¹,Sata Mizuki¹^ORCID,Hirata Aya¹^ORCID,Kuwabara Kazuyo¹,Takeuchi Ayano¹,Sugiyama Daisuke¹,Okamura Tomonori¹^ORCID,Takebayashi Toru¹

Affiliation:

1. Department of Preventive Medicine and Public Health, School of Medicine, Keio University

Publisher

Japan Epidemiological Association

Subject

General Medicine,Epidemiology

Link

https://www.jstage.jst.go.jp/article/jea/31/9/31_JE20200089/_pdf

Reference23 articles.

1. 1. Catapano AL, Graham I, De Backer G, et al; ESC Scientific Document Group. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37(39):2999–3058.

2. 2. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73:3168–3209.

3. 3. Kinoshita M, Yokote K, Arai H, et al; Committee for Epidemiology and Clinical Management of Atherosclerosis. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb. 2018;25(9):846–984.